Vnitr Lek 2001, 47(2):92-98
[High-dosage chemotherapy with support of autologous haematopoietic cells in the treatment of multiple myeloma--review of contemporary possibilities].
- Interni hematoonkologická klinika FN Brno.
High-dosage chemotherapy with autologous transplantation of haematopietic stem cells prolonged the survival of patients with multiple myeloma as compared with results of standard chemotherapy, on average by 1.5 years. Nowadays this method is the standard treatment for suitable patients. Findings assembled recently are discussed by the authors.
Keywords: Antineoplastic Agents, administration & dosage, ; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Multiple Myeloma, therapy, ; Transplantation, Autologous
Published: February 1, 2001 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |